Table 2.
Comparison of different cell-free systems reported in the literature with their significant properties
| Cell-free system origin | Strengths | Weaknesses | Protein examples |
|---|---|---|---|
| Prokaryotic | |||
| Escherichia coli |
CF lysates are simple to prepare and very efficient CFPS is simple with a high yield of proteins within a few hours (depends on protein) Suitable for establishment in large scale in many research laboratories and companies Cost effective and doesn’t need a large infrastructure Highly stable and receptive to external supplements Lysates used for point-of-care testing [30, 31] Wealth of genetic tools and literature |
No PTMs Not suitable for MPs and proteins whose folding function depend on PTMs Lack of translationally active endogenous microsomes Need to supply additional membrane solubilization supplements for MPs Larger proteins (> 70 kDa) prone to higher aggregation or truncated products [47] Contamination with endotoxins |
Trimeric influenza hemagglutinin stem domain (6-h batch): 400 μg/mL [48] NavSp1p (2-h batch): 20 μg/mL [49] PfFNT (CECF overnight): 4 mg/mL [50] TDH (2-h batch): 300 μg/mL [51] Kv 1.3 (4-h batch): 15–25 μg/mL [52] hVDAC1: 10 mg/mL [53] |
| Streptomyces |
Suitable for GC-rich proteins [34] Simple and robust preparation of lysates |
No PTMs reported No endogenous microsomes |
EGFP (3-h batch): 50 µg/mL and (48-h CECF): 282 µg/mL [34] Tbr (P,Q,N,I) and TEII (3-h batch): 11–17 µg/mL [34] |
| Bacillus subtilis |
Alternative to the E. coli-based system Wealth of genetic tools and literature |
No PTMs Lack of translationally active endogenous microsomes Relatively very new and limited reports |
GFP (2.5-h batch): 22 µg/mL [32] Luciferase (1-h batch): 40–150 μg/mL [54] |
| Vibrio natrigens |
Generate a high volume of the active lysate (8–12 mL/1 L culture) [12] Robust lysate preparation and high metabolic efficiency Highly stable at room temperature for 1 wk Higher ribosomal concentration per cell compared with E. coli |
Limited applications until now Relatively very new |
Opistoporin 1: 278 µg/mL [12] Cecropin A: 22 µg/mL [12] Cecropin P1: 96.8 µg/mL [12] EGFP: 400 µg/mL [55] |
| Eukaryotic | |||
| Insect Spodoptera frugiperda 21 (Sf21) |
Mimic the Sf21 cell-based production PTMs (N-glycosylation, disulfide bridging, and lipidation) Suitable for a wide range of eukaryotic and complex proteins Presence of translationally active endogenous microsomes [14] High yields in CECF mode Endotoxin free |
Low yields especially in the batch mode Cost ineffective and difficult to establish unlike E. coli-based system |
KcSA (4 h batch): 8 µg/mL [56] hEGFR (2-h batch): 6 µg/mL [14] (3 × 2-h batch [repetitive]): 15 µg/mL [14] (24-h CECF): 285 µg/mL [57] |
| Chinese hamster ovary (CHO) |
Mimic the CHO cell-based production PTMs (N-glycosylation, disulfide bridging, and lipidation) Suitable for a wide range of eukaryotic and complex proteins Presence of translational active endogenous microsomes [45] High yields in CECF mode Endotoxin free Lysates used for point-of-care testing [30] |
Low yields especially in the batch mode [58] Cost ineffective and difficult to establish unlike E. coli-based system |
Streptokinase (CECF): 500 µg/mL [59] Human TLR9 receptor [18] (3-h batch): 21 µg/mL (48-h CECF): 900 µg/mL hEGFR [46] (batch): 40 µg/mL (CECF): 800 µg/mL |
| Wheat germ |
No codon optimization necessary Highly efficient translation machinery, suitable for a wide variety of proteins including MPs and eukaryotic proteins that do not depend on PTMs for their functionality [47] Alternative to E. coli-based system for producing high yield of proteins Highly stable and resistant to external supplements Promising system for vaccine development No endogenous mRNA |
Lack of endogenous microsomes Need to supply additional solubilization supplements for MPs CF lysate preparation is time consuming Lack of glycosylation |
GFP (3-h batch): 1.6 mg/mL [43] hTERT (48-h CECF): 1.5 mg/mL [58] HRH1 (24-h CECF): 800 µg/mL [60] |
| Tobacco BY-2 |
Very fast lysate preparation (4–5 h) Presence of endogenous microsomes allowing PTMs (glycosylation and disulfide bond) High translational efficiency |
Relatively undeveloped PTMs not well characterized |
Vitronectin-specific full-size human antibody M12 (18-h batch): 150 µg/mL [35] Heparin-binding EGF-like growth factor (HbEGF) (18-h batch): 25 µg/mL [35] Glucose oxidase: 7.34 U/mL [35] |
| Cultured human cells (HeLa, K562 extracts) |
Mimic the human cell-based production PTMs (N-glycosylation, disulfide bridging, and lipidation) Suitable for a wide range of eukaryotic and complex proteins [47] Presence of translationally active endogenous microsomes Endotoxin free |
Low yields and not well established Cost ineffective and difficult to establish unlike E. coli-based system |
Luciferase (2-h batch): 21 µg/mL [62] GST (CECF HeLa): 50 µg/mL [63] hCNTF (6-h batch): 50 µg/mL [61] |
| Rabbit reticulocyte |
Cap-independent translation PTMs Suitable for large complex proteins [64] Easy to prepare |
Low translation efficiency Difficult to prepare lysates Need to externally supply exogenous microsomes for protein folding Ethical issues |
nAChR: no data [44] HBc: no data [65] EGFP (batch): 30 µg/mL [66] FhSAP2 (1.5-h batch): 500 µg/mL [67] |
| Leishmania tarentolae |
Lowest aggregation propensity Better solubility of expressed proteins Background translation of endogenous mRNA suppressed Ease of handling similar to E. coli and offer complete eukaryotic expression |
Protein synthesis only reported for GFP Not so well established No PTMs reported |
EGFP (batch): 300 µg/mL [66] NPT4 (16-h CECF): 50 µg/mL [68] |
| Neurospora | Rapid and inexpensive |
No report of endogenous microsomes No report of PTMs established |
Luciferase (30-min batch): 2.5 µg/mL [37] |
| Saccharomyces cerevisiae |
Easy to prepare Wealth of genetic tools available and cell culture literature Contains eukaryotic folding machinery Lack of endotoxins |
No PTMs reported Low batch yields CF system underdeveloped |
HPV 58 L1 (3-h batch): 60 µg/mL [69] CAT (5-h batch): 10 µg/mL [38] EPO (6-h CECF): 40 µg/mL [70] |
CAT chloramphenicol acetyl transferase, CECF continuous exchange cell-free synthesis, CF cell-free, CFPS cell-free protein synthesis, E. coli Escherichia coli, EGFP enhanced green fluorescent protein, EPO human erythropoietin, FhSAP2 Fasciola hepatica saposin-like protein-2, GC guanine-cytosine, GFP green fluorescent protein, GST glutathione S-transferase, HBc hepatitis B-core protein, hCNTF human ciliary neurotrophic factor, hEGFR human epidermal growth factor receptor, HPV 58 human papillomavirus-58, HRH1 human histamine H1 Receptor, hTERT human telomerase reverse transcriptase, hVDAC1 human voltage dependent anionic channel, KcSA pH-gated potassium channel, Kv1.3 voltage gated potassium channel, MPs membrane proteins, NavSp1p Silicibacter pomeroyi voltage-gated sodium channel, nAChR nicotinic acetylcholine receptor, NPT4 human sodium phosphate transporter 4, PfFNT plasmodium lactate transporter, PTM post-translational modification, TDH thermostable direct hemolysin, Tbr (P,Q,N,I) genes involved in the biosynthesis of peptide tambromycin, TEII type II thioesterase, TLR9 toll-like receptor 9